Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Trxade Group (MEDS)
NASDAQ:MEDS
Holding MEDS?
Track your performance easily
Trxade Group (MEDS) Ownership Overview
41.94% Insiders
1.37% Mutual Funds
1.44% Other Institutional Investors
― ETFs
55.25% Public Companies and
Individual Investors
The ownership structure of Trxade Group (MEDS) stock is a mix of institutional, retail, and individual investors. , 41.94% is owned by Insiders, and 55.25% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,548 | Institution | 0.83% | 110,419 | |
| 14,548 | Institution | 0.83% | 110,419 | |
| 9,374 | Institution | 0.54% | 71,149 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,548 | Institution | 0.83% | 110,419 | |
| 9,374 | Institution | 0.54% | 71,149 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,548 | Institution | 0.83% | 140,825 |
FAQ
Who Owns Trxade Group (MEDS)?
According to the latest TipRanks data, approximately 1.44% of the company's stock is held by institutional investors, 41.94% is held by insiders, and 55.25% is held by retail investors.
What percentage of Trxade Group (MEDS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.44% of Trxade Group (MEDS) stock is held by institutional investors.
What percentage of Trxade Group (MEDS) stock is held by retail investors?
According to the latest TipRanks data, approximately 55.25% of Trxade Group (MEDS) stock is held by retail investors.
Who owns the most shares of Trxade Group (MEDS)?
Vanguard owns the most shares of Trxade Group (MEDS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.